N-ACETYLTRANSFERASE PHENOTYPE OF PATIENTS WITH BLADDER-CANCER

被引：28

作者：

KARAKAYA, AE

COK, I

SARDAS, S

GOGUS, O

SARDAS, OS

机构：

[1] UNIV ANKARA, FAC MED, DEPT UROL, ANKARA, TURKEY

[2] UNIV ANKARA, FAC MED, DEPT HEMATOL & ONCOL, ANKARA, TURKEY

来源：

HUMAN TOXICOLOGY | 1986年 / 5卷 / 05期

关键词：

D O I：

10.1177/096032718600500507

中图分类号：

R99 [毒物学（毒理学）];

学科分类号：

100405 ;

摘要：

引用

页码：333 / 335

页数：3

共 25 条

[1]

ANTHONY HM, 1970, J NATL CANCER I, V45, P879

[2]

CARTWRIGHT RA, 1982, LANCET, V2, P842

[3]

COLE P, 1972, CANCER, V29, P1250, DOI 10.1002/1097-0142(197205)29:5<1250::AID-CNCR2820290518>3.0.CO

[4]

2-T

[5]

EVANS D A P, 1969, Journal of Medical Genetics, V6, P405, DOI 10.1136/jmg.6.4.405

[6]

EVANS DAP, 1964, J LAB CLIN MED, V63, P394

[7] GENETIC CONTROL OF ISONIAZID METABOLISM IN MAN [J].

EVANS, DAP ;

MANLEY, KA ;

MCKUSICK, VA .

BRITISH MEDICAL JOURNAL, 1960, 2 (AUG13) :485-491

[8] THE ASSOCIATION OF THE SLOW ACETYLATOR PHENOTYPE WITH BLADDER-CANCER [J].

EVANS, DAP ;

EZE, LC ;

WHIBLEY, EJ .

JOURNAL OF MEDICAL GENETICS, 1983, 20 (05) :330-333

[9]

GLOWINSKI IB, 1982, J BIOL CHEM, V257, P1424

[10]

GLOWINSKI IB, 1978, MOL PHARMACOL, V14, P940

← 1 2 3 →